Biotage Extends Capabilities with Addition of PEG Resins for Solid Phase Peptide Synthesis

Biotage® announces the addition of ChemMatrix® resins to its extensive offering of peptide synthesis and purification products. ChemMatrix is a patented 100% PEG resin from Matrix Innovation® that offers substantial advantages over traditional PS and PEG based resins for solid phase peptide synthesis.

“Biotage is a leader in the global development of tools and technology for peptide synthesis and purification. Earlier this year, we introduced the SyroWave ® peptide synthesizer, more recently Resolux™ HPLC columns for peptides purification and now ChemMatrix resins.” says Scott Carr, VP of Commercial Operations. “Biotage truly delivers a total solution to professionals in this growing area of science.”

The ChemMatrix resin is a technological tool enabling synthesis of complex molecules from biological origin, peptides, oligionucleotides and small proteins typically used for therapeutic purposes. This resin is supplied as classical spherical beads, a tried and tested solution in the industry for almost 50 years but leverages today’s need for flexibility and exacting standards of quality and performance in the synthesis of especially difficult sequences.

There are many benefits to ChemMatrix, such as; exceptional stability, wide solvent compatibility, no leaching, optimum loading capacity allow users to achieve higher purities and yields of product, per gram of resin, especially in the case of difficult peptide sequences.